Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Thomas Lindqvist"'
Autor:
Mattias Vågberg, Niklas Norgren, Ann Dring, Thomas Lindqvist, Richard Birgander, Henrik Zetterberg, Anders Svenningsson
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135886 (2015)
Neurofilament light (NFL) and Glial Fibrillary Acidic Protein (GFAP) are integral parts of the axonal and astrocytal cytoskeletons respectively and are released into the cerebrospinal fluid (CSF) in cases of cellular damage. In order to interpret the
Externí odkaz:
https://doaj.org/article/0866ef66a6d94444832885de86ca58bd
Publikováno v:
Journal of Neuroradiology. 43:384-391
Brain atrophy is a prominent feature in many neurodegenerative diseases, such as multiple sclerosis, but age-related decrease of brain volume occurs regardless of pathological neurodegeneration. Changes in brain volume can be described by use of the
Autor:
Katarina Laurell, Richard Birgander, Peter Sundström, Pierre de Flon, Wolfgang Krauss, Ann Dring, Thomas Lindqvist, Joakim Bergman, Lars Söderström, Anders Svenningsson, Martin Gunnarsson
Publikováno v:
Neurology. 87:141-147
To describe the effects of switching treatment from ongoing first-line injectable therapies to rituximab on inflammatory activity measured by MRI and levels of CSF neurofilament light chain (CSF-NFL) in a cohort of patients with clinically stable rel
Publikováno v:
Anticancer research. 37(4)
Overall survival for glioblastoma patients is short. Standard treatment is surgery followed by radiochemotherapy and adjuvant temozolomide. The aim of this study was to evaluate the outcome for all patients with progressive disease treated with bevac
Autor:
Martin Gunnarsson, Virginija Danylaité Karrenbauer, Lars Jönsson, Fredrik Piehl, Petra Nilsson, Markus Axelsson, Jan Lycke, Mattias Vågberg, Tobias Granberg, A von Heijne, Richard Birgander, E Mentesidou, S Müller, Joachim Burman, Elna-Marie Larsson, Y Forslin, Carmen Cananau, Magnus Vrethem, Anders Svenningsson, L Lönn, Thomas Lindqvist, Johan Wikström
Publikováno v:
Acta Neurologica Scandinavica
Multiple sclerosis (MS) is associated with inflammatory lesions in the brain and spinal cord. The detection of such inflammatory lesions using magnetic resonance imaging (MRI) is important in the consideration of the diagnosis and differential diagno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63382b6171ed664ff162faa6edf1fdc5
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-302738
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-302738
Autor:
Anders Svenningsson, Mattias Vågberg, Richard Birgander, J. B. M. Warntjes, Peter Sundström, Khalid Ambarki, Thomas Lindqvist
Publikováno v:
AJNR Am J Neuroradiol
BACKGROUND AND PURPOSE: Brain atrophy is a manifestation of tissue damage in MS. Reduction in brain parenchymal fraction is an accepted marker of brain atrophy. In this study, the approach of synthetic tissue mapping was applied, in which brain paren
Autor:
Anders Eklund, Richard Birgander, Khalid Ambarki, Anders Wahlin, Marcel Warntjes, Jan Malm, E. Petterson, Thomas Lindqvist
Publikováno v:
Europe PubMed Central
AJNR Am J Neuroradiol
AJNR Am J Neuroradiol
BACKGROUND AND PURPOSE: Brain size is commonly described in relation to ICV, whereby accurate assessment of this quantity is fundamental. Recently, an optimized MR sequence (QRAPMASTER) was developed for simultaneous quantification of T1, T2, and pro
Autor:
Erik Domellöf, Anna-Maria Johansson, Aijaz Faroogi, Magnus Domellöf, Louise Rönnqvist, Richard Birgander, Thomas Lindqvist, Katrine Riklund
Publikováno v:
Developmental Medicine & Child Neurology. 58:57-57
Background: Children born preterm have a high prevalence of long-term cognitive and behavioral disturbances. Still, studies of how preterm-twin-births may effect brain maturation and thus, contribu ...
Autor:
Peter, Mattsson, Thomas, Lindqvist
Publikováno v:
Lakartidningen. 105(6)
Autor:
Mattias Vågberg, Anders Svenningsson, Tommy Bergenheim, Jonathan D. Gilthorpe, Ann M. Dring, Joakim Bergman, Thomas Lindqvist, Richard Birgander
Publikováno v:
Neurology® Neuroimmunology & Neuroinflammation
Objective: We are conducting an open-label phase 1b study on the efficacy of intrathecal (IT) administration of rituximab, provided via an Ommaya reservoir, for the treatment of progressive multiple sclerosis (PMS). The objective of this initial stud